Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-02-24

Clinical Trial Update: Efficacy of Gabapentin Combined With Solifenacin for Non-neurogenic Overactive Bladder in Women [Phase 3]

View source ↗

Summary

This clinical trial update notes a Phase 3 study evaluating the combination of gabapentin and solifenacin for non-neurogenic overactive bladder in women, with r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gabapentin (Gabapentin)
  • Solifenacin (solifenacin)

Snippet

Sponsor: Mansoura University | Conditions: Overactive Bladder | Phase 3 | Status: NOT_YET_RECRUITING